Related Experiment Video
Updated: May 27, 2026
07:12
Chronic Post-Ischemia Pain Model for Complex Regional Pain Syndrome Type-I in Rats
Published on: January 21, 2020
MicroRNA modulation in complex regional pain syndrome
Irina A Orlova1, Guillermo M Alexander, Rehman A Qureshi
1Pharmacology & Physiology, Drexel University College of Medicine, Philadelphia, PA 19102, USA.
Journal of Translational Medicine
|November 15, 2011
Summary
MicroRNA (miRNA) profiles in blood can help stratify patients with complex regional pain syndrome (CRPS). These differentially expressed miRNAs may serve as biomarkers for pain and offer new therapeutic targets for CRPS.
Area of Science:
- Biochemistry
- Genetics
- Immunology
Background:
- Aberrant microRNA (miRNA) expression is implicated in various human diseases.
- Complex Regional Pain Syndrome (CRPS) is a heterogeneous chronic pain condition with central and/or peripheral nervous system dysfunction.
- Identifying specific miRNA modulations in CRPS patients is crucial for understanding disease mechanisms.
Purpose of the Study:
- To identify differentially expressed miRNAs in the blood of CRPS patients.
- To explore the utility of these miRNAs in stratifying CRPS patients.
- To investigate the relationship between miRNA profiles, inflammatory markers, and clinical parameters in CRPS.
Main Methods:
- miRNA profiling was performed on whole blood samples from 41 CRPS patients and 20 controls using TaqMan low density array cards.
- Inflammatory markers (chemokines, cytokines, soluble receptors) were measured to assess neurogenic inflammation.
- Correlation analyses were conducted between miRNA expression, inflammatory markers, disease symptoms, medication, and comorbidities.
Main Results:
- Three distinct miRNA profile groups were identified, with one group containing 60% of CRPS patients and no controls.
- Eighteen miRNAs were found to be differentially expressed in CRPS patients.
- Elevated levels of vascular endothelial growth factor (VEGF), interleukin-1 receptor antagonist (IL1Ra), and monocyte chemotactic protein-1 (MCP1) were observed in CRPS patients, with VEGF and IL1Ra correlating with pain levels.
Conclusions:
- miRNA profiles demonstrate potential for CRPS patient stratification and serve as biomarkers for pain.
- Differentially expressed miRNAs offer molecular insights into gene regulation relevant to CRPS.
- These findings could pave the way for novel therapeutic strategies targeting miRNA pathways in CRPS.
Related Concept Videos
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...